Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure? (Q44123593)
scientific article
Language:
(P31) (Q13442814)
(Q871232)
(P304) 195-197
(P407) (Q1860)
(P433) 2-3
(P478) 85
(P577) Tuesday, October 1, 2002
(P921) (Q181754)
(P1433) (Q2357863)
(P1476) "Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?" (language: en)
(P2093) Paul R Kalra
James C C Moon
Andrew J S Coats
(P2860) (Q33824143)
(Q34363699)
(Q73096903)
(Q73999661)
(Q77110358)
(Q34353349)
(Q40925312)
(Q73627047)
other details
description scientific article

External Links